Pharma News

How artificial intelligence M&A performed in the pharmaceutical industry in Q2 2023

In value terms, artificial intelligence-related deal activity increased by 45% in Q2 2023 compared with the previous quarter’s total of $131.8m. Related deal volume increased by 50% in Q2 2023 versus the previous quarter and was 100% higher than in Q2 2022.

The top-ranked legal advisors supporting these M&A deals in Q2 2023 were Wilson Sonsini Goodrich & Rosati Professional; Gibson, Dunn & Crutcher; Gillespie Law Group with 2, 1, 1 deals respectively.

For further understanding of GlobalData’s Generative Artificial Intelligence (AI) Powerplay: What’s in the Big Tech AI Playbook, buy the report here.

This content was updated on 18 July 2023




Source link
#artificial #intelligence #performed #pharmaceutical #industry

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *